-
公开(公告)号:US11992555B2
公开(公告)日:2024-05-28
申请号:US17448263
申请日:2021-09-21
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K9/08 , A61K9/14 , A61K31/12 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/216 , A61K31/25 , A61K31/337 , A61K31/357 , A61K31/366 , A61K31/4178 , A61K31/4184 , A61K31/522 , A61K31/60 , A61K31/616 , A61K31/704 , A61K47/10 , A61K47/14 , A61K31/19 , A61K31/201
CPC classification number: A61K9/08 , A61K9/148 , A61K31/12 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/216 , A61K31/357 , A61K31/366 , A61K31/4178 , A61K31/4184 , A61K31/522 , A61K31/60 , A61K31/616 , A61K47/10 , A61K47/14 , A61K31/19 , A61K31/201 , A61K31/25 , A61K31/337 , A61K31/704
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US11202831B2
公开(公告)日:2021-12-21
申请号:US16882666
申请日:2020-05-25
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K9/08 , A61K47/10 , A61K47/14 , A61K31/121 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/222 , A61K31/357 , A61K31/366 , A61K31/4178 , A61K31/4184 , A61K31/522 , A61K31/616 , A61K47/22 , A61K47/44 , A61K31/60 , A61K9/14 , A61K9/20
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US20210137864A1
公开(公告)日:2021-05-13
申请号:US17146950
申请日:2021-01-12
Applicant: Infirst Healthcare Limited
Inventor: Robin Mark Bannister , John Brew , Wilson Caparros-Wanderley , Gregory Alan Stoloff , Suzanne Jane Dilly , Gemma Szucs , Olga Pleguezuelos Mateo
IPC: A61K31/192 , A61K9/20 , A61K47/34 , A61K47/14 , A61K47/44 , A61K9/08 , A61K47/10 , A61K31/196 , A61K31/60
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US20210128505A1
公开(公告)日:2021-05-06
申请号:US17146989
申请日:2021-01-12
Applicant: Infirst Healthcare Limited
Inventor: Robin Mark Bannister , John Brew , Wilson Caparros-Wanderley , Gregory Alan Stoloff , Suzanne Jane Dilly , Gemma Szucs , Olga Pleguezuelos Mateo
IPC: A61K31/192 , A61K9/20 , A61K47/34 , A61K47/14 , A61K47/44 , A61K9/08 , A61K47/10 , A61K31/196 , A61K31/60
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US10420812B2
公开(公告)日:2019-09-24
申请号:US16042670
申请日:2018-07-23
Applicant: Infirst Healthcare Limited
Inventor: John Brew , Robin Mark Bannister
IPC: A61K31/522 , A61K31/485 , A61K36/534 , A61K45/06 , A61K9/00 , A61K9/08 , A61K31/375
Abstract: The present specification discloses compositions comprising a plurality of therapeutic compound having antitussive activity and methods and uses for treating a coughing condition with such compositions.
-
公开(公告)号:US10363232B2
公开(公告)日:2019-07-30
申请号:US15684197
申请日:2017-08-23
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew
IPC: A61K31/192 , A61K47/10 , A61K47/14 , A61K9/08 , A61K47/44 , A61K9/20 , A61K31/196 , A61K31/60 , A61K9/06 , A61K9/00 , A61K9/48 , A61K31/436 , A61K31/194 , A61K31/381 , A61K31/4035 , A61K31/421 , A61K31/423 , A61K31/19
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US20190070137A1
公开(公告)日:2019-03-07
申请号:US16166272
申请日:2018-10-22
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K31/192 , A61K47/44 , A61K47/22 , A61K9/08 , A61K9/20 , A61K31/12 , A61K31/121 , A61K31/196 , A61K47/14 , A61K47/10 , A61K31/616 , A61K31/60 , A61K31/201 , A61K31/202 , A61K31/704 , A61K31/25 , A61K31/337
CPC classification number: A61K31/192 , A61K9/08 , A61K9/2013 , A61K31/12 , A61K31/121 , A61K31/196 , A61K31/201 , A61K31/202 , A61K31/25 , A61K31/337 , A61K31/60 , A61K31/616 , A61K31/704 , A61K47/10 , A61K47/14 , A61K47/22 , A61K47/44 , Y02A50/411
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US10213381B2
公开(公告)日:2019-02-26
申请号:US15684214
申请日:2017-08-23
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K9/08 , A61K9/14 , A61K31/12 , A61K31/19 , A61K31/25 , A61K31/60 , A61K47/10 , A61K47/14 , A61K31/137 , A61K31/167 , A61K31/192 , A61K31/196 , A61K31/201 , A61K31/216 , A61K31/337 , A61K31/357 , A61K31/366 , A61K31/522 , A61K31/616 , A61K31/704 , A61K31/4178 , A61K31/4184
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US20180050003A1
公开(公告)日:2018-02-22
申请号:US15794197
申请日:2017-10-26
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K31/192 , A61K47/44 , A61K9/08 , A61K47/14 , A61K47/10 , A61K47/22 , A61K9/20 , A61K31/12 , A61K31/121 , A61K31/196 , A61K31/616 , A61K31/60 , A61K31/25 , A61K31/337 , A61K31/201 , A61K31/202 , A61K31/704
CPC classification number: A61K31/192 , A61K9/08 , A61K9/2013 , A61K31/12 , A61K31/121 , A61K31/196 , A61K31/201 , A61K31/202 , A61K31/25 , A61K31/337 , A61K31/60 , A61K31/616 , A61K31/704 , A61K47/10 , A61K47/14 , A61K47/22 , A61K47/44 , Y02A50/411
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
公开(公告)号:US20180050002A1
公开(公告)日:2018-02-22
申请号:US15794178
申请日:2017-10-26
Applicant: Infirst Healthcare Limited
Inventor: Robin M. Bannister , John Brew , Richard R. Reiley, III , Wilson Caparros Wanderley
IPC: A61K31/192 , A61K47/44 , A61K9/08 , A61K47/14 , A61K47/10 , A61K47/22 , A61K9/20 , A61K31/12 , A61K31/121 , A61K31/196 , A61K31/616 , A61K31/60 , A61K31/25 , A61K31/337 , A61K31/201 , A61K31/202 , A61K31/704
CPC classification number: A61K31/192 , A61K9/08 , A61K9/2013 , A61K31/12 , A61K31/121 , A61K31/196 , A61K31/201 , A61K31/202 , A61K31/25 , A61K31/337 , A61K31/60 , A61K31/616 , A61K31/704 , A61K47/10 , A61K47/14 , A61K47/22 , A61K47/44 , Y02A50/411
Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
-
-
-
-
-
-
-
-
-